Literature DB >> 22893419

Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model.

J J Wendler1, M Porsch, S Hühne, D Baumunk, P Buhtz, F Fischbach, M Pech, D Mahnkopf, S Kropf, A Roessner, J Ricke, M Schostak, U-B Liehr.   

Abstract

PURPOSE: Irreversible electroporation (IRE) is a novel nonthermal tissue ablation technique by high current application leading to apoptosis without affecting extracellular matrix. Previous results of renal IRE shall be supplemented by functional MRI and differentiated histological analysis of renal parenchyma in a chronic treatment setting.
METHODS: Three swine were treated with two to three multifocal percutaneous IRE of the right kidney. MRI was performed before, 30 min (immediate-term), 7 days (short-term), and 28 days (mid-term) after IRE. A statistical analysis of the lesion surrounded renal parenchyma intensities was made to analyze functional differences depending on renal part, side and posttreatment time. Histological follow-up of cortex and medulla was performed after 28 days.
RESULTS: A total of eight ablations were created. MRI showed no collateral damage of surrounded tissue. The highest visual contrast between lesions and normal parenchyma was obtained by T2-HR-SPIR-TSE-w sequence of DCE-MRI. Ablation zones showed inhomogeneous necroses with small perifocal edema in the short-term and sharp delimitable scars in the mid-term. MRI showed no significant differences between adjoined renal parenchyma around ablations and parenchyma of untreated kidney. Histological analysis demonstrated complete destruction of cortical glomeruli and tubules, while collecting ducts, renal calyxes, and pelvis of medulla were preserved. Adjoined kidney parenchyma around IRE lesions showed no qualitative differences to normal parenchyma of untreated kidney.
CONCLUSIONS: This porcine IRE study reveals a multifocal renal ablation, while protecting surrounded renal parenchyma and collecting system over a mid-term period. That offers prevention of renal function ablating centrally located or multifocal renal masses.

Entities:  

Mesh:

Year:  2012        PMID: 22893419     DOI: 10.1007/s00270-012-0452-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  20 in total

1.  Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties.

Authors:  Eliel Ben-David; Muneeb Ahmed; Mohammad Faroja; Marwan Moussa; Ayelet Wandel; Jacob Sosna; Liat Appelbaum; Isaac Nissenbaum; S Nahum Goldberg
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

Review 2.  Renal ablation update.

Authors:  Vishal Khiatani; Robert G Dixon
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 3.  Technical and practical considerations for device selection in locoregional ablative therapy.

Authors:  Sean P Zivin; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

4.  In vivo evaluation of bronchial injury of irreversible electroporation in a porcine lung ablation model by using laboratory, pathological, and CT findings.

Authors:  Jun-Hui Sun; Tong-Yin Zhu; Xin-Hua Chen; Chun-Hui Nie; Zhi-Gang Ren; Guan-Hui Zhou; Tan-Yang Zhou; Sheng-Yong Yin; Zhi-Yi Peng; Li-Ming Wu; Xiong-Xin Zhang; Wei-Lin Wang; Shu-Sen Zheng
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

5.  Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days.

Authors:  Govindarajan Srimathveeravalli; Francois Cornelis; Thomas Wimmer; Sebastien Monette; Simon Y Kimm; Majid Maybody; Stephen B Solomon; Jonathan A Coleman; Jeremy C Durack
Journal:  J Vasc Interv Radiol       Date:  2017-03-30       Impact factor: 3.464

Review 6.  [Irreversible electroporation. Current value for focal treatment of prostate cancer].

Authors:  J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

7.  Feasibility of catheter-directed intraluminal irreversible electroporation of porcine ureter and acute outcomes in response to increasing energy delivery.

Authors:  Govindarajan Srimathveeravalli; Mikhail Silk; Thomas Wimmer; Sebastien Monette; Simon Kimm; Majid Maybody; Stephen B Solomon; Jonathan Coleman; Jeremy C Durack
Journal:  J Vasc Interv Radiol       Date:  2015-03-11       Impact factor: 3.464

8.  Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.

Authors:  Katie S Murray; Behfar Ehdaie; John Musser; Joseph Mashni; Govindarajan Srimathveeravalli; Jeremy C Durack; Stephen B Solomon; Jonathan A Coleman
Journal:  J Urol       Date:  2016-04-23       Impact factor: 7.450

Review 9.  Irreversible Electroporation (IRE) in Renal Tumors.

Authors:  Govindarajan Narayanan; Mehul H Doshi
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

10.  Planning irreversible electroporation in the porcine kidney: are numerical simulations reliable for predicting empiric ablation outcomes?

Authors:  Thomas Wimmer; Govindarajan Srimathveeravalli; Narendra Gutta; Paula C Ezell; Sebastien Monette; Majid Maybody; Joseph P Erinjery; Jeremy C Durack; Jonathan A Coleman; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2014-05-17       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.